Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

被引:16
|
作者
Bajorath, Juergen [1 ]
机构
[1] Rhein Freidrich Wilhelms Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, D-53113 Bonn, Germany
关键词
chemical biology; chemogenomics; computational methods; drug-target networks; ligand selectivity; ligand-target interactions; pharmacological space; polypharmacology; small molecules; target families;
D O I
10.1517/17460440802536496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Chemical biology and chemogenomics are rapidly evolving disciplines at interfaces between chemistry and the life sciences and are highly interdisciplinary in nature. Chemogenomics has a strong conceptional link to modern drug discovery research, whereas chemical biology focuses more on the use of small molecules as probes for exploring biological functions, rather than drug candidates. However, the boundaries between these areas are fluid, as they should be, given their strong interdisciplinary orientation. Objective: Recently, computational approaches have been introduced for the analysis of research topics that are of considerable relevance for these disciplines including, for example, the systematic study of ligand-target interactions or mapping of pharmacologically relevant chemical space. This contribution introduces key investigations in computational chemical biology and chemogenomics and critically evaluates their current and future potential to impact drug discovery. Conclusions: Computational methods of high relevance for chemogenomics and chemical biology either derive knowledge from large-scale analysis of available drug and target data or interface experimental programs with predictive methods. Approaches for drug target prediction and the systematic analysis of polypharmacology substantially impact research in this area.
引用
收藏
页码:1371 / 1376
页数:6
相关论文
共 50 条
  • [21] Click chemistry patents and their impact on drug discovery and chemical biology
    Xu, Hua
    Jones, Lyn H.
    PHARMACEUTICAL PATENT ANALYST, 2015, 4 (02) : 109 - 119
  • [22] Current Advances in Computational Approaches for Drug Discovery-Part I
    Gupta, Amit K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (26) : 2201 - 2201
  • [23] Current Advances in Computational Approaches for Drug Discovery-Part II
    Gupta, Amit K.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (27) : 2267 - 2267
  • [24] Target Discovery Driven by Chemical Biology and Computational Biology
    Lyu, Bohai
    Gou, Wenfeng
    Xu, Feifei
    Chen, Leyuan
    Wang, Zhiyun
    Ren, Zhonghao
    Liu, Gaiting
    Li, Yiliang
    Hou, Wenbin
    CHEMICAL RECORD, 2025, 25 (03):
  • [25] Computational approaches streamlining drug discovery
    Sadybekov, Anastasiia V.
    Katritch, Vsevolod
    NATURE, 2023, 616 (7958) : 673 - 685
  • [26] NOVEL COMPUTATIONAL APPROACHES TO DRUG DISCOVERY
    Skolnick, Jeffrey
    Brylinski, Michal
    QUANTUM BIO-INFORMATICS III: FROM QUANTUM INFORMATION TO BIO-INFORMATICS, 2010, 26 : 327 - 336
  • [27] Computational Approaches to Anesthetic Drug Discovery
    McGrath, Megan
    Pence, Andrea
    Raines, Douglas E.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (11) : 809 - 811
  • [28] Computational approaches streamlining drug discovery
    Anastasiia V. Sadybekov
    Vsevolod Katritch
    Nature, 2023, 616 : 673 - 685
  • [29] Chemogenomics for drug discovery: clinical molecules from open access chemical probes
    Quinlan, Robert B. A.
    Brennan, Paul E.
    RSC CHEMICAL BIOLOGY, 2021, 2 (03): : 759 - 795
  • [30] Chemical biology impacting drug discovery
    Ende, Christopher Am
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257